Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-26 @ 2:44 AM
Study NCT ID:
NCT00771602
Status:
TERMINATED
Last Update Posted:
2015-06-23
First Post:
2008-10-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Alemtuzumab + Rituximab Consolidation in CLL
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-10
First Submit QC Date:
None
Study First Post Date:
2008-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-04
Results First Submit QC Date:
None
Results First Post Date:
2011-04-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-27
Last Update Post Date:
2015-06-23
Last Update Post Date Type:
ESTIMATED